TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: treatment efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage of Participants With a Clinical Response of Cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative percent agreement (NPA) of the Anthrax LF Dx System test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimal stent area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Isometric shoulder strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shoulder Pain and Disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Shoulder Range Of Motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remaining submucous fibroids volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: participation and activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: acceptability of Stroke Odysseys
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinically relevant device migration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Accuracy of automatic segmentation algorithm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Qalb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in TGF-beta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: ctDNA dynamic detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with hematoma occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of percentage of graft take adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of participants that require re-operation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Bleeding during operation
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of Conversion to open cholecystectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Plasma concentration sufentanil/fentanyl
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentration naloxone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective Stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in Hospital Anxiety and Depression -anxiety subscale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in Hospital Anxiety and Depression -depression subscale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Safety of Administered dose
Endpoint domain: Adverse events/effects
Primary endpoint: Dosimetry of [18F]RP-115
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biodistribution of [18F]RP-115
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of ultrasound signs in assessing morbidly adherent placenta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Accuracy of pro forma in assessing extent of morbidly adherent placenta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Accuracy of pro forma in assessing depth of invasion of placenta accreta spectrum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Patient Empowerment Scale (PES)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sperm Progressive Motility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Number of participants with Sinus rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants with Atrial fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants with Premature atrial beats
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants with Ventricular premature beats
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change in hypothalamic-pituitary-gonadal axis function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number and severity of adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Glycated hemoglobin (HbA1c) value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: knee extension angles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knee moments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Failure of biceps recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abundance and phenotypes of immune cell subtypes within tumor or normal tonsil tissues
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Abundance and phenotypes of peripheral blood T cell subtypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Quality of Recovery Score (ObsQoR-11)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Maternal Satisfaction Scale for Cesarean Section (MSSCS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Satisfaction with Received Care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Plasma uncarboxylated matrix gla protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Subjects With COVID-19 Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in baseline Pain
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change in baseline Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Fear of medical procedures
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Plasma concentrations of pro-inflammatory oxylipins
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of VR
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline in family functioning and cohesion
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change from baseline in child problem behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in substance use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cortisol Stress Reactivity and Recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Electrodermal Activity (EDA) arousal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perception of PET/CT imaging agent Y-90
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perception of PET/CT imaging agent NaF
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perception of MRI contrast agents
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Composite Score on Self-efficacy Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Increase of blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Bimanual performance/functional hand use
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Breast Self Examination Practice Skill Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of women tested for HIV, syphilis and hepatitis B
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of grade 3 and 4 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants that had a neoantigen-specific DNA vaccine generated
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in mean LESS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in snack intake by weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in snack intake by energy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of VAS score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change of CTCAE version 4
Endpoint domain: Adverse events/effects
Primary endpoint: Change of Skindex-16
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mean pain visual pain score during latent phase of labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean pain visual pain score during active phase of labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain visual pain score 2 hours post delivery of labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of labour during active phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NEuroPSYcology evaluations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Travel willingness
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Actual decision to vaccinate child against HPV
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Changes in score on MoCA
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: The incidences of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Accuracy of machine learning algorithms for predicting high-risk persons
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of machine learning algorithms for discriminating high-risk and low-risk lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of intersegmental plane identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nausea, Vomiting, and Retching
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Feasibility of Text-Messaging System
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Usefulness and Acceptability of the Text4US program
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Effectiveness of the Text4US program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Gross Motor Function Scale (GMFS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfactory basic life support performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change in Hepatic De Novo Lipogenesis (DNL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Anxiety and Depression Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Functional Status Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Depression, Anxiety, Stress Score (DASS-21)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Implementation of decision aids for colorectal cancer screening
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Facilitators and barriers to cancer screening and prevention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient knowledge, attitudes, and beliefs regarding cancer screening
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Understanding and treatment of pediatric cardiovascular disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pharmacokinetic parameters of CBD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-week complete response (CR) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of triage for CIN2+ detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Contralateral plantarflexor muscle activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Hip extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Step length symmetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of patients with a dry ear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite measure of suicide awareness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Progression Free Survival Time (PFS2)
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of evaluable participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with immunogenicity 3 to 5 weeks following vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvement in endoscopic visualisation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence and prevalence of perioperative cerebrovascular stroke
Endpoint domain: Mortality/survival
Primary endpoint: Solicited clinical (local and systemic) adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Procedure-related dyspnea scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Procedure-related pain scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: General patient satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Uptake of low-dose computed tomography lung cancer screening services
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of alive patients
Endpoint domain: Mortality/survival
Primary endpoint: Change in burnout syndrome
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in professional fulfillment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Incidence of adverse events (AEs) defined as DLT
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with an infection at the fracture site
Endpoint domain: Adverse events/effects
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Predictive validity of the IMS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morbidity related to bone marrow aspirations
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Neuropathic Pain Symptom Inventory score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Frequency of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence rate of hyperglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of patients with device success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with composite of in-hospital cardiac death or myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: 30-day major renal adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Renal venous return
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Renal microcirculation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of participants with solicited injection site or systemic reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Number of images collected
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Occurrence of adverse events related to the viral challenge
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of serious adverse events related to the viral challenge
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients with clinically relevant alterations identified by F1Heme testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intranasal adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Percent of subjects maintaining clear or almost clear on PGA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prostate-specific antigen (PSA)-response rate (PSA-RR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With PrEP Initiation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Participants Who Persisted On PrEP After Initiation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Spleen volume reduction (SVR35)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Echo changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Variation in osteoarthritis related pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PK similarity of AVT05 with Simponi
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Executive functions and self-regulation
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Hidradenitis Suppurativa Clinical Response (HiSCR75)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Children's Depression Rating Scale- Revised (CDRS-R)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Functional Capacity (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Functional Capacity (CPET)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in diaphragm hypertrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Psychological readiness to return to sport
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient reported knee function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Jumping height in hop tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Disability of Neck
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Neurological Outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: congestion measured by the CPM wearable device
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in congestion measured by the CPM wearable device
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of vitreoretinal surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Geometric Mean Ratios (GMRs) of Full-Length S-Binding IgG Concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric Mean Ratios (GMRs) of SARS-CoV-2 Neutralizing Titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Antiviral effect of INNA-051
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the Level of physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in physiological arousal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in functional MRI data in fear-learning circuitry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: upper esophageal sphincter pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Perception of breast milk
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Graft-versus-host disease (GVHD)-free and relapse-free (GRFS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: uMRD (<10-4)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean Change in Amblyopic Eye Visual Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptance to patients of clinical trial procedures
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Interest in participation in genital herpes vaccine trials
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to Result
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cost Efficiency
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of retention
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change of weight from baseline to week 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes